<scp><i>How do we</i></scp>…form and coordinate a national serosurvey of <scp>SARS‐CoV</scp>‐2 within the blood collection industry?

Abstract

The study adapted operations as the pandemic evolved, changing specimen flow and testing algorithms, and collecting additional data elements in response to changing policies on universal blood donation screening and administration of SARS-CoV-2 spike-based vaccines. The national serosurvey demonstrated the utility of serosurveillance testing of residual blood donations and highlighted the role of the blood collection industry in public-private partnerships during a public health emergency.